Global and United States Nanopharmaceuticals Market Insights, Forecast to 2027

Global and United States Nanopharmaceuticals Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Nanopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Nanopharmaceuticals Market Size Growth Rate by Type
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid Lipid Nanoparticles
1.2.5 Microemulsion and Nnanoemulsion
1.2.6 Nanosuspension
1.3 Market by Application
1.3.1 Global Nanopharmaceuticals Market Size Growth Rate by Application
1.3.2 Cancer and Tumor
1.3.3 Autoimmune Disorders
1.3.4 Inflammation
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nanopharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global Nanopharmaceuticals Revenue 2016-2027
2.1.2 Global Nanopharmaceuticals Sales 2016-2027
2.2 Global Nanopharmaceuticals, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Nanopharmaceuticals Historical Market Size by Region (2016-2021)
2.3.1 Global Nanopharmaceuticals Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Nanopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Nanopharmaceuticals Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Nanopharmaceuticals Sales Forecast by Region (2022-2027)
2.4.2 Global Nanopharmaceuticals Revenue Forecast by Region (2022-2027)
3 Global Nanopharmaceuticals Competitor Landscape by Players
3.1 Global Top Nanopharmaceuticals Manufacturers by Sales
3.1.1 Global Nanopharmaceuticals Sales by Manufacturer (2016-2021)
3.1.2 Global Nanopharmaceuticals Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Nanopharmaceuticals Manufacturers by Revenue
3.2.1 Key Nanopharmaceuticals Manufacturers Covered: Ranking by Revenue
3.2.2 Global Nanopharmaceuticals Revenue by Manufacturers (2016-2021)
3.2.3 Global Nanopharmaceuticals Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Nanopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Nanopharmaceuticals Revenue in 2020
3.2.6 Global Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nanopharmaceuticals Price by Manufacturers
3.4 Global Nanopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Nanopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nanopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Nanopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Nanopharmaceuticals Market Size by Type (2016-2021)
4.1.1 Global Nanopharmaceuticals Sales by Type (2016-2021)
4.1.2 Global Nanopharmaceuticals Revenue by Type (2016-2021)
4.1.3 Nanopharmaceuticals Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Nanopharmaceuticals Market Size Forecast by Type (2022-2027)
4.2.1 Global Nanopharmaceuticals Sales Forecast by Type (2022-2027)
4.2.2 Global Nanopharmaceuticals Revenue Forecast by Type (2022-2027)
4.2.3 Nanopharmaceuticals Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Nanopharmaceuticals Market Size by Application (2016-2021)
5.1.1 Global Nanopharmaceuticals Sales by Application (2016-2021)
5.1.2 Global Nanopharmaceuticals Revenue by Application (2016-2021)
5.1.3 Nanopharmaceuticals Price by Application (2016-2021)
5.2 Nanopharmaceuticals Market Size Forecast by Application (2022-2027)
5.2.1 Global Nanopharmaceuticals Sales Forecast by Application (2022-2027)
5.2.2 Global Nanopharmaceuticals Revenue Forecast by Application (2022-2027)
5.2.3 Global Nanopharmaceuticals Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Nanopharmaceuticals Market Size YoY Growth 2016-2027
6.1.1 United States Nanopharmaceuticals Sales YoY Growth 2016-2027
6.1.2 United States Nanopharmaceuticals Revenue YoY Growth 2016-2027
6.1.3 United States Nanopharmaceuticals Market Share in Global Market 2016-2027
6.2 United States Nanopharmaceuticals Market Size by Players (International and Local Players)
6.2.1 United States Top Nanopharmaceuticals Players by Sales (2016-2021)
6.2.2 United States Top Nanopharmaceuticals Players by Revenue (2016-2021)
6.3 United States Nanopharmaceuticals Historic Market Review by Type (2016-2021)
6.3.1 United States Nanopharmaceuticals Sales Market Share by Type (2016-2021)
6.3.2 United States Nanopharmaceuticals Revenue Market Share by Type (2016-2021)
6.3.3 United States Nanopharmaceuticals Price by Type (2016-2021)
6.4 United States Nanopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Nanopharmaceuticals Sales Forecast by Type (2022-2027)
6.4.2 United States Nanopharmaceuticals Revenue Forecast by Type (2022-2027)
6.4.3 United States Nanopharmaceuticals Price Forecast by Type (2022-2027)
6.5 United States Nanopharmaceuticals Historic Market Review by Application (2016-2021)
6.5.1 United States Nanopharmaceuticals Sales Market Share by Application (2016-2021)
6.5.2 United States Nanopharmaceuticals Revenue Market Share by Application (2016-2021)
6.5.3 United States Nanopharmaceuticals Price by Application (2016-2021)
6.6 United States Nanopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Nanopharmaceuticals Sales Forecast by Application (2022-2027)
6.6.2 United States Nanopharmaceuticals Revenue Forecast by Application (2022-2027)
6.6.3 United States Nanopharmaceuticals Price Forecast by Application (2022-2027)
7 North America
7.1 North America Nanopharmaceuticals Market Size YoY Growth 2016-2027
7.2 North America Nanopharmaceuticals Market Facts & Figures by Country
7.2.1 North America Nanopharmaceuticals Sales by Country (2016-2021)
7.2.2 North America Nanopharmaceuticals Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Nanopharmaceuticals Market Size YoY Growth 2016-2027
8.2 Asia Pacific Nanopharmaceuticals Market Facts & Figures by Region
8.2.1 Asia Pacific Nanopharmaceuticals Sales by Region (2016-2021)
8.2.2 Asia Pacific Nanopharmaceuticals Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Nanopharmaceuticals Market Size YoY Growth 2016-2027
9.2 Europe Nanopharmaceuticals Market Facts & Figures by Country
9.2.1 Europe Nanopharmaceuticals Sales by Country (2016-2021)
9.2.2 Europe Nanopharmaceuticals Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Nanopharmaceuticals Market Size YoY Growth 2016-2027
10.2 Latin America Nanopharmaceuticals Market Facts & Figures by Country
10.2.1 Latin America Nanopharmaceuticals Sales by Country (2016-2021)
10.2.2 Latin America Nanopharmaceuticals Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Nanopharmaceuticals Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Nanopharmaceuticals Market Facts & Figures by Country
11.2.1 Middle East and Africa Nanopharmaceuticals Sales by Country (2016-2021)
11.2.2 Middle East and Africa Nanopharmaceuticals Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Nanopharmaceuticals Products Offered
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Nanopharmaceuticals Products Offered
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Nanopharmaceuticals Products Offered
12.3.5 Novartis Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Description and Business Overview
12.4.3 Abbott Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbott Nanopharmaceuticals Products Offered
12.4.5 Abbott Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Description and Business Overview
12.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GlaxoSmithKline Nanopharmaceuticals Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Description and Business Overview
12.6.3 Roche Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Roche Nanopharmaceuticals Products Offered
12.6.5 Roche Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Description and Business Overview
12.7.3 Sanofi Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sanofi Nanopharmaceuticals Products Offered
12.7.5 Sanofi Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Corporation Information
12.8.2 Eli Lilly Description and Business Overview
12.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Eli Lilly Nanopharmaceuticals Products Offered
12.8.5 Eli Lilly Recent Development
12.9 Astrazeneca
12.9.1 Astrazeneca Corporation Information
12.9.2 Astrazeneca Description and Business Overview
12.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Astrazeneca Nanopharmaceuticals Products Offered
12.9.5 Astrazeneca Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Corporation Information
12.10.2 Johnson & Johnson Description and Business Overview
12.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Johnson & Johnson Nanopharmaceuticals Products Offered
12.10.5 Johnson & Johnson Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Nanopharmaceuticals Products Offered
12.11.5 Merck Recent Development
12.12 Novavax
12.12.1 Novavax Corporation Information
12.12.2 Novavax Description and Business Overview
12.12.3 Novavax Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Novavax Products Offered
12.12.5 Novavax Recent Development
12.13 Stryker
12.13.1 Stryker Corporation Information
12.13.2 Stryker Description and Business Overview
12.13.3 Stryker Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Stryker Products Offered
12.13.5 Stryker Recent Development
12.14 Gilead Sciences
12.14.1 Gilead Sciences Corporation Information
12.14.2 Gilead Sciences Description and Business Overview
12.14.3 Gilead Sciences Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Gilead Sciences Products Offered
12.14.5 Gilead Sciences Recent Development
12.15 OSI Pharmaceuticals
12.15.1 OSI Pharmaceuticals Corporation Information
12.15.2 OSI Pharmaceuticals Description and Business Overview
12.15.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.15.4 OSI Pharmaceuticals Products Offered
12.15.5 OSI Pharmaceuticals Recent Development
12.16 Kadmon Pharmaceuticals
12.16.1 Kadmon Pharmaceuticals Corporation Information
12.16.2 Kadmon Pharmaceuticals Description and Business Overview
12.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Kadmon Pharmaceuticals Products Offered
12.16.5 Kadmon Pharmaceuticals Recent Development
12.17 Samyang Biopharm
12.17.1 Samyang Biopharm Corporation Information
12.17.2 Samyang Biopharm Description and Business Overview
12.17.3 Samyang Biopharm Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Samyang Biopharm Products Offered
12.17.5 Samyang Biopharm Recent Development
12.18 Mitsubishi Pharma
12.18.1 Mitsubishi Pharma Corporation Information
12.18.2 Mitsubishi Pharma Description and Business Overview
12.18.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Mitsubishi Pharma Products Offered
12.18.5 Mitsubishi Pharma Recent Development
12.19 Kaken Pharmaceutical
12.19.1 Kaken Pharmaceutical Corporation Information
12.19.2 Kaken Pharmaceutical Description and Business Overview
12.19.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Kaken Pharmaceutical Products Offered
12.19.5 Kaken Pharmaceutical Recent Development
12.20 Selecta Biosciences
12.20.1 Selecta Biosciences Corporation Information
12.20.2 Selecta Biosciences Description and Business Overview
12.20.3 Selecta Biosciences Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Selecta Biosciences Products Offered
12.20.5 Selecta Biosciences Recent Development
12.21 Par Pharmaceutical
12.21.1 Par Pharmaceutical Corporation Information
12.21.2 Par Pharmaceutical Description and Business Overview
12.21.3 Par Pharmaceutical Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Par Pharmaceutical Products Offered
12.21.5 Par Pharmaceutical Recent Development
12.22 Cerulean Pharma
12.22.1 Cerulean Pharma Corporation Information
12.22.2 Cerulean Pharma Description and Business Overview
12.22.3 Cerulean Pharma Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Cerulean Pharma Products Offered
12.22.5 Cerulean Pharma Recent Development
12.23 Navidea Biopharmaceuticals
12.23.1 Navidea Biopharmaceuticals Corporation Information
12.23.2 Navidea Biopharmaceuticals Description and Business Overview
12.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Navidea Biopharmaceuticals Products Offered
12.23.5 Navidea Biopharmaceuticals Recent Development
12.24 Lummy
12.24.1 Lummy Corporation Information
12.24.2 Lummy Description and Business Overview
12.24.3 Lummy Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Lummy Products Offered
12.24.5 Lummy Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Nanopharmaceuticals Industry Trends
13.2 Nanopharmaceuticals Market Drivers
13.3 Nanopharmaceuticals Market Challenges
13.4 Nanopharmaceuticals Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nanopharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Nanopharmaceuticals Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Liposomes
Table 3. Major Manufacturers of Polymeric Micelles
Table 4. Major Manufacturers of Solid Lipid Nanoparticles
Table 5. Major Manufacturers of Microemulsion and Nnanoemulsion
Table 6. Major Manufacturers of Nanosuspension
Table 7. Global Nanopharmaceuticals Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 8. Global Nanopharmaceuticals Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Nanopharmaceuticals Sales by Regions (2016-2021) & (K MT)
Table 10. Global Nanopharmaceuticals Sales Market Share by Regions (2016-2021)
Table 11. Global Nanopharmaceuticals Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Nanopharmaceuticals Sales Forecast by Region (2022-2027) & (K MT)
Table 13. Global Nanopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Nanopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Nanopharmaceuticals Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Nanopharmaceuticals Sales by Manufacturers (2016-2021) (K MT)
Table 17. Global Nanopharmaceuticals Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Nanopharmaceuticals Manufacturers by Revenue (US$ Million) in 2020
Table 19. Nanopharmaceuticals Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Nanopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 21. Global Nanopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Nanopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanopharmaceuticals as of 2020)
Table 23. Key Manufacturers Nanopharmaceuticals Price (2016-2021) (USD/MT)
Table 24. Nanopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Nanopharmaceuticals Product Type
Table 26. Date of International Manufacturers Enter into Nanopharmaceuticals Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Nanopharmaceuticals Sales by Type (2016-2021) (K MT)
Table 29. Global Nanopharmaceuticals Sales Share by Type (2016-2021)
Table 30. Global Nanopharmaceuticals Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Nanopharmaceuticals Revenue Share by Type (2016-2021)
Table 32. Nanopharmaceuticals Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 33. Global Nanopharmaceuticals Sales Forecast by Type (2022-2027) & (K MT)
Table 34. Global Nanopharmaceuticals Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Nanopharmaceuticals Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Nanopharmaceuticals Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Nanopharmaceuticals Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 38. Global Nanopharmaceuticals Sales by Application (2016-2021) (K MT)
Table 39. Global Nanopharmaceuticals Sales Share by Application (2016-2021)
Table 40. Global Nanopharmaceuticals Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Nanopharmaceuticals Revenue Share by Application (2016-2021)
Table 42. Nanopharmaceuticals Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 43. Global Nanopharmaceuticals Sales Forecast by Application (2022-2027) & (K MT)
Table 44. Global Nanopharmaceuticals Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Nanopharmaceuticals Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Nanopharmaceuticals Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Nanopharmaceuticals Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 48. United States Nanopharmaceuticals Sales (K MT) of Key Companies (2016-2021)
Table 49. United States Nanopharmaceuticals Sales Share by Company (2016-2021)
Table 50. United States Nanopharmaceuticals Revenue (US$ Million) by Company (2016-2021)
Table 51. United States Nanopharmaceuticals Revenue Share by Company (2016-2021)
Table 52. United States Nanopharmaceuticals Sales (K MT) by Type (2016-2021)
Table 53. United States Nanopharmaceuticals Sales Share by Type (2016-2021)
Table 54. United States Nanopharmaceuticals Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. United States Nanopharmaceuticals Price (USD/MT) by Type (2016-2021)
Table 56. United States Nanopharmaceuticals Sales (K MT) by Type (2022-2027)
Table 57. United States Nanopharmaceuticals Sales Share by Type (2022-2027)
Table 58. United States Nanopharmaceuticals Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. United States Nanopharmaceuticals Revenue Share by Type (2022-2027)
Table 60. United States Nanopharmaceuticals Price (USD/MT) by Type (2022-2027)
Table 61. United States Nanopharmaceuticals Sales (K MT) by Application (2016-2021)
Table 62. United States Nanopharmaceuticals Sales Share by Application (2016-2021)
Table 63. United States Nanopharmaceuticals Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. United States Nanopharmaceuticals Price (USD/MT) by Application (2016-2021)
Table 65. United States Nanopharmaceuticals Sales (K MT) by Application (2022-2027)
Table 66. United States Nanopharmaceuticals Sales Share by Application (2022-2027)
Table 67. United States Nanopharmaceuticals Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. United States Nanopharmaceuticals Revenue Share by Application (2022-2027)
Table 69. United States Nanopharmaceuticals Price (USD/MT) by Application (2022-2027)
Table 70. North America Nanopharmaceuticals Sales by Country (2016-2021) & (K MT)
Table 71. North America Nanopharmaceuticals Sales Market Share by Country (2016-2021)
Table 72. North America Nanopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Nanopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Nanopharmaceuticals Sales by Region (2016-2021) & (K MT)
Table 75. Asia Pacific Nanopharmaceuticals Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Nanopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Nanopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 78. Europe Nanopharmaceuticals Sales by Country (2016-2021) & (K MT)
Table 79. Europe Nanopharmaceuticals Sales Market Share by Country (2016-2021)
Table 80. Europe Nanopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Nanopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 82. Latin America Nanopharmaceuticals Sales by Country (2016-2021) & (K MT)
Table 83. Latin America Nanopharmaceuticals Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Nanopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Nanopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Nanopharmaceuticals Sales by Country (2016-2021) & (K MT)
Table 87. Middle East and Africa Nanopharmaceuticals Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Nanopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Nanopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 93. Merck Nanopharmaceuticals Product
Table 94. Merck Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 103. Novartis Product
Table 104. Novartis Recent Development
Table 105. Abbott Corporation Information
Table 106. Abbott Description and Business Overview
Table 107. Abbott Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 108. Abbott Product
Table 109. Abbott Recent Development
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Business Overview
Table 112. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. GlaxoSmithKline Product
Table 114. GlaxoSmithKline Recent Development
Table 115. Roche Corporation Information
Table 116. Roche Description and Business Overview
Table 117. Roche Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Roche Product
Table 119. Roche Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Sanofi Product
Table 124. Sanofi Recent Development
Table 125. Eli Lilly Corporation Information
Table 126. Eli Lilly Description and Business Overview
Table 127. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Eli Lilly Product
Table 129. Eli Lilly Recent Development
Table 130. Astrazeneca Corporation Information
Table 131. Astrazeneca Description and Business Overview
Table 132. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Astrazeneca Product
Table 134. Astrazeneca Recent Development
Table 135. Johnson & Johnson Corporation Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Johnson & Johnson Product
Table 139. Johnson & Johnson Recent Development
Table 140. Celgene Corporation Information
Table 141. Celgene Description and Business Overview
Table 142. Celgene Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Celgene Product
Table 144. Celgene Recent Development
Table 145. Novavax Corporation Information
Table 146. Novavax Description and Business Overview
Table 147. Novavax Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 148. Novavax Product
Table 149. Novavax Recent Development
Table 150. Stryker Corporation Information
Table 151. Stryker Description and Business Overview
Table 152. Stryker Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 153. Stryker Product
Table 154. Stryker Recent Development
Table 155. Gilead Sciences Corporation Information
Table 156. Gilead Sciences Description and Business Overview
Table 157. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Gilead Sciences Product
Table 159. Gilead Sciences Recent Development
Table 160. OSI Pharmaceuticals Corporation Information
Table 161. OSI Pharmaceuticals Description and Business Overview
Table 162. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. OSI Pharmaceuticals Product
Table 164. OSI Pharmaceuticals Recent Development
Table 165. Kadmon Pharmaceuticals Corporation Information
Table 166. Kadmon Pharmaceuticals Description and Business Overview
Table 167. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Kadmon Pharmaceuticals Product
Table 169. Kadmon Pharmaceuticals Recent Development
Table 170. Samyang Biopharm Corporation Information
Table 171. Samyang Biopharm Description and Business Overview
Table 172. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Samyang Biopharm Product
Table 174. Samyang Biopharm Recent Development
Table 175. Mitsubishi Pharma Corporation Information
Table 176. Mitsubishi Pharma Description and Business Overview
Table 177. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Mitsubishi Pharma Product
Table 179. Mitsubishi Pharma Recent Development
Table 180. Kaken Pharmaceutical Corporation Information
Table 181. Kaken Pharmaceutical Description and Business Overview
Table 182. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Kaken Pharmaceutical Product
Table 184. Kaken Pharmaceutical Recent Development
Table 185. Selecta Biosciences Corporation Information
Table 186. Selecta Biosciences Description and Business Overview
Table 187. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Selecta Biosciences Product
Table 189. Selecta Biosciences Recent Development
Table 190. Par Pharmaceutical Corporation Information
Table 191. Par Pharmaceutical Description and Business Overview
Table 192. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 193. Par Pharmaceutical Product
Table 194. Par Pharmaceutical Recent Development
Table 195. Cerulean Pharma Corporation Information
Table 196. Cerulean Pharma Description and Business Overview
Table 197. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 198. Cerulean Pharma Product
Table 199. Cerulean Pharma Recent Development
Table 200. Navidea Biopharmaceuticals Corporation Information
Table 201. Navidea Biopharmaceuticals Description and Business Overview
Table 202. Navidea Biophar

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nanopharmaceuticals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 153

According to our LPI (LP Information) latest study, the global Nanopharmaceuticals market size was valued at US$ 30290 million in 2023. With growing demand in downstream market, the Nanopharmaceuticals is forecast to a readjusted size of US$ 73420 million by 2030 with a CAGR of 13.5% during review period. The research report highlights the growth potential of the global Nanopharmaceuticals market. Nanopharmaceuticals are expected to show stable growth in the future market. However, produ......

Global Nanomedicine Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 87

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nanomedicine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Combimatrix - Ablynx - Abraxis Bioscience - Celgene - Mallinckrodt - Arrowhead Research - GE Healthcare - Merck - Pfizer - Na......

Global Nanomedicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 116

Market Overview of Global Nanomedicine market: According to our latest research, the global Nanomedicine market looks promising in the next 5 years. As of 2022, the global Nanomedicine market was estimated at USD 181.26 million, and it's anticipated to reach USD 263.67 million in 2028, with a CAGR of 6.45% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nanomedicine market, with......

Nanomaterials in Personalized Medicine: Global Markets

Published: 20-Oct-2023        Price: US 5500 Onwards        Pages: 226

Report Scope: The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competiti......

2023-2031 Report on Global Nanopharmaceuticals Market by Player, Region, Type, Application and Sales Channel

Published: 09-Oct-2023        Price: US 2500 Onwards        Pages: 122

This report studies the Nanopharmaceuticals market, covering market size for segment by type (Liposomes, Polymeric Micelles, etc.), by application (Cancer and Tumor, Autoimmune Disorders, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Na......

Global Cancer Nanomedicine Market Insights, Forecast to 2029

Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 111

Nanomedicine is a branch of nanotechnology that uses nanoparticles to diagnose, treat, monitor, and control biological systems. By manipulating materials at the nanoscale, it improves medicine delivery. As a result, nanomedicine has helped treat a wide range of diseases. Nanomedicine is still in its infancy, with numerous products in the works. Nanobiotix has identified 230 nanomedicine products that are either patented or in the early stages of development. 49 of the 230 products are on the mar......

Asia-Pacific Nanotechnology In Energy Applications Market Forecast 2023-2032

Published: 18-Aug-2023        Price: US 1600 Onwards        Pages: 175

KEY FINDINGS The Asia-Pacific nanotechnology in energy applications market is projected to grow with a CAGR of 13.24% during the forecasting years of 2023-2032. The regional market's growth is ascribed to the gradual improvement of the nanotechnology profile in scientific research, supportive government policies and regulations aimed at promoting renewable energy as well as reducing carbon footprint, and rising concerns associated with greenhouse emissions and safety. ......

Europe Nanotechnology In Energy Applications Market Forecast 2023-2032

Published: 18-Aug-2023        Price: US 1600 Onwards        Pages: 165

KEY FINDINGS The Europe nanotechnology in energy applications market is set to grow with a CAGR of 12.89% over the forecast period of 2023-2032. The regional market's growth is accredited to the European Union's (EU) significant role in promoting nanotechnology in the energy sector as well as the efforts directed toward the transition to a low-carbon economy and minimizing greenhouse gas emissions. MARKET INSIGHTS The United Kingdom, Italy, Spain, Pol......

North America Nanotechnology In Energy Applications Market Forecast 2023-2032

Published: 18-Aug-2023        Price: US 1600 Onwards        Pages: 168

KEY FINDINGS The North America nanotechnology in energy applications market is estimated to record a CAGR of 13.01% over the forecast period of 2023-2032. The market growth of the region is augmented by increasing customer demand for high-performance, longer-lasting products, the introduction of new standards and technologies, as well as evolving regulatory requirements. MARKET INSIGHTS Canada and the United States are evaluated for the North America ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs